Skin Cancer Surveillance Program for Solid Organ Transplant Recipients
JAMA Dermatology 10.1001/jamadermatol.2025.3890October 15, 2025 at 11:00 AM EDT
How does a risk assessment−based skin cancer surveillance program affect screening rates and outcomes among solid organ transplant (SOT) recipients?This retrospective cohort study including 2083 SOT recipients matched with 26 199 nonrecipients found that SOT recipients had a 7.8-fold increased risk of developing posttransplant skin cancer. The skin cancer surveillance program improved screening rates and increased the risk of first-detected skin cancer in higher-risk groups without increasing short-term health care utilization.These findings indicate that risk-stratified surveillance enhanced early skin cancer detection in higher-risk SOT recipients without added burden on health care resources, supporting its utility as a targeted screening approach.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.